
Galux Raises $29M in Series B Funding to Advance AI-Driven Protein Design for Drug Discovery
Galux Raises $29M Series B to Advance AI-Driven Protein Design for Drug Discovery Galux, a South Korea-based biotech pioneering AI-driven protein therapeutics design, today announced the successful completion of a $29 million (KRW 42 billion) Series B financing. With this…












